beta-Nicotimamide-Adenine Dinucleotide Reduced (NADH)

CAT:
952-B2013881
Size:
50 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
beta-Nicotimamide-Adenine Dinucleotide Reduced (NADH) - image 1

beta-Nicotimamide-Adenine Dinucleotide Reduced (NADH)

  • Description:

    beta-Nicotimamide-Adenine Dinucleotide Reduced (NADH)_x000D_ Catalog number: B2013881_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 mg_x000D_ Molecular Weight or Concentration: 709.4 kDa_x000D_ Supplied as: Powder_x000D_ Applications: molecular tool for various biochemical applications_x000D_ Storage: ˆ’20°C_x000D_ Keywords: beta-Nicotimamide-Adenine Dinucleotide, Reduced (NADH)_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Abdellatif M, Sedej S, Kroemer G. NAD(+) Metabolism in Cardiac Health, Aging, and Disease Circulation. 2021 Nov 30;144(22):1795-1817._x000D_ 2: Lin Q, Zuo W, Liu Y, Wu K, Liu Q. NAD(+) and cardiovascular diseases Clin Chim Acta. 2021 Apr;515:104-110._x000D_ 3: Xiao W, Wang RS, Handy DE, Loscalzo J. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism Antioxid Redox Signal. 2018 Jan 20;28(3):251-272._x000D_ 4: Quinn WJ 3rd, Jiao J, TeSlaa T, Stadanlick J, Wang Z, Wang L, Akimova T, Angelin A, Sch_fer PM, Cully MD, Perry C, Kopinski PK, Guo L, Blair IA, Ghanem LR, Leibowitz MS, Hancock WW, Moon EK, Levine MH, Eruslanov EB, Wallace DC, Baur JA, Beier UH. Lactate Limits T Cell Proliferation via the NAD(H) Redox State Cell Rep. 2020 Dec 15;33(11):108500._x000D_ 5: Anderson KA, Madsen AS, Olsen CA, Hirschey MD. Metabolic control by sirtuins and other enzymes that sense NAD(+), NADH, or their ratio Biochim Biophys Acta Bioenerg. 2017 Dec;1858(12):991-998._x000D_ 6: Ye M, Zhao Y, Wang Y, Xie R, Tong Y, Sauer JD, Gong S. NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis Nat Nanotechnol. 2022 Aug;17(8):880-890._x000D_ 7: Chiao YA, Chakraborty AD, Light CM, Tian R, Sadoshima J, Shi X, Gu H, Lee CF. NAD(+) Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy Circ Heart Fail. 2021 Aug;14(8):e008170._x000D_ 8: Immanuel S, Sivasubramanian R, Gul R, Dar MA. Recent Progress and Perspectives on Electrochemical Regeneration of Reduced Nicotinamide Adenine Dinucleotide (NADH) Chem Asian J. 2020 Dec 14;15(24):4256-4270._x000D_ 9: Forte M, Bianchi F, Cotugno M, Marchitti S, De Falco E, Raffa S, Stanzione R, Di Nonno F, Chimenti I, Palmerio S, Pagano F, Petrozza V, Micaloni A, Madonna M, Relucenti M, Torrisi MR, Frati G, Volpe M, Rubattu S, Sciarretta S. Pharmacological restoration of autophagy reduces hypertension-related stroke occurrence Autophagy. 2020 Aug;16(8):1468-1481._x000D_ 10: Koju N, Qin ZH, Sheng R. Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe? Acta Pharmacol Sin. 2022 Aug;43(8):1889-1904. _x000D_ _x000D_ Products Related to beta-Nicotimamide-Adenine Dinucleotide Reduced (NADH) can be found at Chemicals
  • Short Description:

    Catalog Number: B2013881 (50 mg)_x000D_ beta-Nicotimamide-Adenine Dinucleotide Reduced (NADH) is a high quality beta-Nicotimamide-Adenine Dinucleotide, Reduced (NADH). This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request._x000D_ _x000D_
  • Weight:

    0.15
  • Length:

    2
  • Width:

    0.5
  • Height :

    0.5